NOVEL BACTERIOPHAGE AND TREATMENT AGENT FOR BACTERIAL ENDOPHTHALMITIS

摘要

The purpose of the present invention is to provide a novel bacteriophage effective for the treatment of bacterial endophthalmitis and a treatment agent for bacterial endophthalmitis that contains this novel bacteriophage. The bacterial endophthalmitis treatment agent according to the present invention is characterized by containing at least one bacteriophage selected from the group indispensably consisting of Myoviridae Spounavirinae phiEF7H (Accession No.: NITE BP-02886), Myoviridae Spounavirinae phiEF19G (Accession No.: NITE BP-02887), Myoviridae Spounavirinae phiEF14H1 (Accession No.: NITE BP-02888), and mutants thereof.